Diet Drug Acomplia Sales Disappoint; No Major Improvement Seen Until 2009
Sales of diet drug Acomplia (rimonabant) , available in Europe but not approved in the U.S., have turned into a major disappointment for Sanofi-Aventis, which says it does not expect the situation to significantly improve until new clinical trial results are ready for submission to regulators in [...]
OTHER DIETARY SUPPLEMENTS FOR WEIGHT LOSS
OTHER DIETARY SUPPLEMENTS FOR WEIGHT LOSS
Dehydroepiandosterone (DHEA)
DHEA is an adrenal hormone that is a precursor to the sex hormones testosterone and estrogen, as well as other hormones. DHEA is reported to increase testosterone and decrease total body fat, and also to have anabolic and anti-aging effects. The anabolic effects are of particular importance.Abuses [...]
FDA Advisory Panel Says Obese Kids Should Be Included in Drug Trials
A U.S. FDA Advisory Committee reviewing guidelines for weight-loss drug trials appear prepared to call for studies that focus on the effect of anti–obesity drugs on severely obese children Acomplia (rimonabant) .
Acomplia (rimonabant) “This population of patients needs to be studied separately from the [...]
DRUGS APPROVED BY THE FDA FOR WEIGHT LOSS
DRUGS APPROVED BY THE FDA FOR WEIGHT LOSS
Drugs approved for use in weight loss programs can be broken
down into the following categories:
1. Anorexiants (drugs that work on chemicals in the brain)
a. Amphetamines
1. Benzphetamine (Didrex®)
2. Diethylpriopion (Tenuate®; Tenuate Dospan®)
3. Methamphetamine (Desoxyn®)
4. Phentermine (Adipex®; Adipex®-P or Ionamin®)
b. Sibutramine (Meridia®)
2. Lipase Inhibitors (drugs [...]
Phenylpropanolamine
Phenylpropanolamine
Phenylpropanolamine is similar to amphetamine, but does not cause euphoria and does not have the same potential for abuse. Phenylpropanolamine was used as a cough and cold agent initially, since it relieves congestion associated with the common cold. Before long, people realized that it caused appetite suppression and that they were able to lose [...]
Experimental Obesity Drug APD356 Reported Effective in Small, Short Trial
A year ago at this time, millions of overweight and obese An experimental drug for the treatment of obesity, APD356, reportedly produced encouraging results in a relatively small four week clinical trial, according to a statement released by Arena Pharmaceuticals, Inc Acomplia (rimonabant) .
Arena said [...]
Roche, GlaxoSmithKline Sign Promotional Agreement for Xenical in U.S.
Pharmaceutical giants Roche and GlaxoSmithKline have signed a promotional agreement for weight-loss medication Xenical (orlistat) in the United States, according to a statement issued April 12th.
The pact gives Glaxo exclusive rights to promote prescription Xenical in the United States. Glaxo also acquired the rights to an over-the-counter (OTC) version of the [...]
Study: Acomplia Increases the Likelihood of Success in Quitting Smoking
Researchers at the University of Cincinnati Acomplia (rimonabant) College of Medicine presented results of one of the largest smoking cessation trials ever conducted in the United States, STRATUS-US (STudies with Rimonabant And Tobacco USe). The findings show that a new drug, rimonabant, doubled the odds of quitting smoking compared [...]
